How Healthtech Companies Should Compare Executive Search Firms

What should healthtech companies compare?

Compare sector knowledge and role specialization. Reputation tells you who markets well. Evidence tells you who delivers a commercial leader who survives contact with your market.

The stakes here are concentrated in a single hire. Senior commercial roles turn over fast even in stable industries, and Spencer Stuart's annual study put average tenure for Fortune 500 chief marketing officers at 4.2 years in 2023, the shortest of any C-suite role it tracks. A healthtech company selling into health systems with 12-month procurement cycles can't absorb a leader who leaves at month fourteen.

That's the real comparison. You're buying the probability that the person you hire is still building pipeline when your next funding round opens. So weight every question below by how directly it predicts that outcome, and discount anything a firm can claim without showing you something.

Does the firm understand healthtech?

Healthtech knowledge means understanding your buyer and your regulatory exposure. A firm that recruited for a medical device distributor isn't automatically equipped to find a VP of Sales for a reimbursement-dependent software company.

Test it with the regulatory question first. The U.S. Food and Drug Administration's public list now covers more than 1,000 AI-enabled medical devices that have been authorized for marketing, and a commercial leader at one of those companies has to sell inside constraints that a wellness app leader never encounters. Ask the firm to describe those constraints in their own words. Firms with relevant experience should be able to explain those constraints clearly and concretely.

Here's the inference most companies miss. Regulatory pathway shapes who the buyer is, and the buyer shapes which executives can actually sell to them. If a firm can't trace that chain for your product category, their candidate judgment will be built on pattern matching from a different industry.

Which comparable searches have they completed?

Ask for anonymized searches that match on the role and your company stage. Then ask what happened to those placements after twelve and twenty-four months.

Stage matters more than most firms admit. Rock Health reported that U.S. digital health startups raised $10.1 billion across 497 deals in 2024, which means the pool of companies at any given funding stage is small and the executives who've operated at that stage are smaller still. A Series B company needs someone who's built a first sales motion.

Retention data is the tell. Firms that track it will give you numbers and context on the exits. Firms that do not track retention may take a more limited view of their role after placement, which is worth understanding when you compare post-hire support.

Do they specialize in this role?

Confirm the firm can describe what success looks like in this specific function before you let them represent you. Market access leadership and enterprise sales leadership share a title level and almost nothing else.

Gallup's research across 2.5 million manager-led teams found that the manager alone accounts for 70% of the variance in team engagement. Scale that to a commercial function and the person you hire sets the ceiling on every rep and marketer below them. A firm without relevant functional specialization may struggle to distinguish between executives who look similar on paper but have very different experience in the commercial challenges your team faces.

Ask the firm to write the success profile themselves, before you share yours. What should this person have accomplished by day 180? If their answer is a list of generic leadership traits rather than a measurable commercial outcome, that may indicate limited specialization in the function or company stage.

Is their executive network relevant?

Ask two numbers: how many viable candidates the firm already knows by name today, and how many more they expect to find. The gap between those figures tells you whether you're buying a network or a research project.

LinkedIn Talent Solutions estimates that roughly 70% of the global workforce is passive talent, which means people who aren't searching for jobs. The healthtech commercial leaders you want are almost entirely in that group, because the good ones are mid-quota and mid-equity-vest. Anyone who applies to your posting is self-selecting out of a situation, and you should know which situation.

So push the firm to separate the two pools explicitly in their reporting. Active applicants aren't disqualified, but they shouldn't be presented alongside proven passive executives without the distinction being visible. If a firm does not distinguish between those pools, it becomes harder to judge the strength and relevance of the shortlist.

How rigorous is the search process?

A credible firm walks you through every stage before you sign, from role definition through what they do after the acceptance. Vague answers at this stage become vague execution at week six.

The onboarding piece is where most comparisons end too early. Michael Watkins, in The First 90 Days, puts the breakeven point for a new leader at roughly 6.2 months, the moment they've contributed as much value as they've consumed. For a healthtech commercial hire facing long enterprise sales cycles, that breakeven lands even later, which means the firm's involvement should extend past the start date rather than stopping at the signature.

Ask what the firm does in months one through three. Some will offer structured check-ins with both sides. Others will say the engagement closes at acceptance, which is an honest answer and a reason to weight them lower if your last commercial leader left early. The process you're buying either ends at a hire or at a working executive.

Is progress visible throughout the search?

Ask for a redacted sample of a real weekly report before you sign anything. The document should show outreach volume and whatever the firm now considers a risk to the timeline.

The Association of Executive Search and Leadership Consultants, whose members sign its Code of Professional Practice, commits firms to keeping clients informed of search progress on a regular basis. That's a floor. A report that says "continued outreach, three candidates progressing" meets the letter of it and tells you nothing you can act on.

What you want is the uncomfortable material. If four strong prospects declined because your equity package reads as below market, that's a finding you need in week three. Firms that surface bad news early are also the firms that will tell your finalist something true about the role.

How are candidates assessed?

Compare the actual methods. Structured interviews and written scorecards each do different jobs, and a firm should be able to say which one answers which question about your shortlist.

Google's re:Work guidance on structured interviewing documents the core mechanic: asking every candidate the same questions and grading answers against a defined rubric makes comparisons between people meaningful. Unstructured conversations produce confident opinions that don't line up across interviewers.

No assessment method predicts performance with certainty, and any firm promising that is selling you something it can't deliver. What good assessment does is reduce how much of your decision rests on a likable ninety minutes. Insist that every scored dimension traces back to an outcome you've named for the role. Those outcomes should then be translated into specific competencies, structured interview questions, and scorecard criteria so that every candidate is evaluated against the same evidence standard rather than generic executive presence.

How does the firm support diversity?

Ask how the firm builds and measures the breadth of its candidate pool, and treat guarantees about who ends up in the final slate as a warning rather than a selling point. Sourcing is a process you can audit. Outcomes aren't something a firm should be promising.

A 2016 analysis of 598 job finalists by Stefanie Johnson and David Hekman found that when a four-person finalist pool included only one woman, her statistical odds of being hired were close to zero. The composition of the pool shaped the decision before interviews began.

The practical read: where a firm stops searching determines what you get to choose from. So ask for the research map and the point at which the firm decided the longlist was complete. That's auditable evidence of effort, and it keeps the conversation on sourcing practice rather than on the characteristics of individual candidates.

How does each firm manage risk?

Risk sits in the contract and the process, so read both before the pitch impresses you. Confidentiality handling and replacement terms belong in writing.

Selection practice carries its own exposure. The U.S. Equal Employment Opportunity Commission's guidance on employment tests and selection procedures explains that selection tools used in hiring decisions are subject to federal anti-discrimination requirements, and this is an area where you should take your own counsel's view rather than a search firm's. If a firm administers assessments on your behalf, ask what validation evidence exists for the instrument and who holds responsibility for its use.

Off-limits clauses deserve the same scrutiny. A firm with twelve healthtech clients has twelve companies it can't recruit from, which quietly shrinks your addressable market. Ask for that list, in writing, before you hand over the mandate.

How will confidentiality be protected?

Establish who inside the firm touches your information and how outreach describes your company before a non-disclosure agreement is signed. Get it in the engagement letter.

Healthtech raises the stakes because the search itself can leak commercially sensitive information. Firms operating around companies governed by the HIPAA Privacy Rule should understand why a careless reference call into a customer health system is a problem beyond etiquette. Ask how they brief candidates on what they can and can't repeat.

Succession and competitive replacement searches each need a different cover story, and the firm should propose one rather than wait for you to. If you're replacing a sitting executive who doesn't know yet, confirm in writing how many people at the firm will be told, and what the outreach script says when a candidate asks why the role is open.

Are timelines and communication realistic?

Require a milestone schedule with dates attached to deliverables, plus one named person who owns communication. A firm that commits to a completion date without first seeing your market map is guessing.

For context on pace, SHRM's benchmarking research put the average time to fill at 44 days across all roles. Senior commercial searches in a narrow healthtech category run far longer, because the qualified population is counted in dozens and each candidate needs weeks to get comfortable leaving a vesting schedule.

The useful signal is whether a firm names its dependencies. Strong partners will tell you that your CEO's availability for final-round interviews is the likeliest bottleneck, or that your compensation band will add three weeks of search. That's a firm planning against reality. A firm quoting a fixed eight-week timeline without discussing those dependencies should prompt additional questions about how the estimate was developed.

Are fees and replacement terms clear?

Get total expected cost and the exact conditions that void a replacement before you sign. Ambiguity here can create unnecessary risk for the client, so the terms should be clarified before the engagement begins.

Scale sets the context. SHRM's benchmarking put the average cost per hire at $4,700 across roles, while a retained executive search priced against a senior commercial package runs into six figures. You're paying a multiple, and you should know precisely what triggers each installment.

Three terms deserve specific attention in your comparison:

• What voids the guarantee. A replacement clause that excludes resignations or restructures covers almost nothing, because those are the ways most executive exits actually happen.

• Whether replacement means a new search or a refund, and who decides.

• What you owe if you cancel at week five, and whether paid installments carry forward to a future mandate.

Push for the replacement clause to survive a change in your reporting structure. Reorganizations are common at growth stage, and a hire who ends up reporting to a new chief revenue officer shouldn't lose you your protection.

Which questions reveal credible expertise?

The questions that work demand artifacts and outcome data. Ask what the firm would challenge in your brief, and you'll learn more in five minutes than an hour of capability deck will teach you.

Daniel Kahneman and colleagues documented how much unstructured professional judgment varies: at one insurance company, the median difference between two underwriters pricing the same risk was 55%, five times larger than executives had predicted. Search consultants assessing the same candidate are subject to the same spread. That's why process artifacts matter more than consultant intuition.

Questions worth asking in every first meeting:

• Show me a redacted scorecard and the reference questions you'd ask for this role.

• What's wrong with the job description I sent you?

• Which candidates will you refuse to put forward, and why?

The last one separates partners from vendors. A firm that will tell you a candidate is strong on enterprise selling and weak on building a team from scratch is doing analysis. A firm that promises speed and access is describing effort, which isn't the same thing as judgment.

How should firms be scored?

Build a weighted scorecard before the first meeting, with weights set by the risks specific to this role. If your last two commercial leaders failed on channel strategy, channel evidence gets the heaviest weight, and charm gets none.

Peter Cappelli, a management professor at Wharton, wrote that only about a third of U.S. companies monitor whether their hiring practices actually produce good employees. The same blind spot applies to choosing a search partner. Most companies never revisit whether the firm they picked predicted the outcome they got.

So document as you go. Score each firm on the same evidence categories and separate must-haves from preferences before you compare totals, because a firm that aces the preferences while missing a must-have will still win on points if you don't split them. Then store the scorecard. Twelve months after the placement, it becomes the only honest record of whether your selection criteria were measuring the right things.

Have you defined the mandate first?

Define the mandate before you contact a single firm. Write the outcomes the hire owns in year one and the evidence standard each one has to meet. Every comparison in this guide depends on that document existing, because without it you're scoring firms against a brief they wrote for you.

That's the step most growth-stage companies skip, and it's the one that determines whether the search finds the right person or a plausible one. A firm can't be held to a specification you never set.

TruAlign Partners works with growth-stage MedTech companies on critical commercial leadership hires and supports this job-definition step directly. Before outreach begins, the team defines the outcomes a hire needs to achieve and translates those outcomes into competencies, structured interview questions, and scorecard criteria. CarbonCore helps consolidate stakeholder evaluation and candidate evidence throughout the process, while behavioral assessment tools such as McQuaig can provide an additional data point where appropriate.

Start by writing the first-year outcomes for the role. Bring that document to your first conversation with any firm and ask them what they'd change about it. Contact TruAlign.